CTCAE RápidoAdverse event grades · CTCAE v6.0
Código Onco

Forced expiratory volume decreased

Investigations
  1. G1FEV1% (percentages of observed FEV1 and FVC related to their respective predicted values) 99 - 70% predicted; Global Lung Function Initiative (GLI) Z-score -1.65 to -2.5
  2. G2FEV1% 60 - 69%; GLI Z-score <-2.5 to -4
  3. G3FEV1% 50 - 59%; GLI Z-score <-4
  4. G4Not applicable
  5. G5Not applicable
Definition and note

DefinitionA finding based on test results that indicate a relative decrease in the fraction of the forced vital capacity that is exhaled in a specific number of seconds.

Navigational noteConsider Respiratory, thoracic and mediastinal disorders: Dyspnea, Respiratory failure.

MedDRA code (LLT): 10016987 · CTCAE v6.0 (NCI), original English text.

Other events in Investigations

Activated partial thromboplastin time prolongedAlanine aminotransferase increasedAlkaline phosphatase increasedAspartate aminotransferase increasedBlood antidiuretic hormone abnormalBlood bicarbonate decreasedBlood bilirubin increasedBlood corticotrophin decreasedBlood gonadotrophin abnormalBlood lactate dehydrogenase increasedBlood prolactin abnormalCarbon monoxide diffusing capacity decreasedCD4 lymphocytes decreasedCholesterol highCreatinine clearance decreasedCreatinine increasedElectrocardiogram QT corrected interval prolongedFibrinogen decreasedGGT increasedGrowth hormone abnormalHaptoglobin decreasedHDL decreasedHemoglobin increasedINR increased

Search another event

From the same authorCódigo OncoCódigo Onco (in Portuguese): Brazilian public health system (SUS) codes for systemic cancer treatment.